Hassle free Returns FREE Shipping on orders above 500/- Cash On Delivery

Support 0484 4080450 | support@curegarden.in

P.J. Kunjachan becomes VC of the Spices Board of India

Posted on 27-12-16

P. J. Kunjachan, Managing Director of Arjuna Natural Extracts Limited has been selected as the Vice Chairman of the Spices Board of India for the year 2012-13. This is a prestigious moment in the journey of ANEL.

Mr. Kunjachan started his career in the field of herbal extracts with a company called Arjuna Aromatics and rose to head a company now targeting a turnover of Rs 100 crore. ANEL is the largest manufacturer of omega-3 fatty acids in Asia and is now the producer of the world’s largest selling bio-available turmeric extract, BCM-95™.

BCM-95™, developed by ANEL scientists, has obtained six patents from the US and one from Japan; the European patent is pending. ANEL has world-class facilities approved by the Ministry of Science and Technology, Government of India for in-house research, experts comprising clinicians, ayurvedic physicians, phytochemists, botanists and scientists manufacturing more than 40 standard herbal/spice extracts, and marketing in over 40 countries.



Curegarden represents a dream. A dream of sharing a happier, healthier body and quality of life with the use of nature's best ingredients. Botanics, when extracted for their bioactive compounds, offer a most effective approach to improving well-being and quality of life. It is based on the belief that botanicals of the highest quality would have a positive effect — without any negative side effects — on people's health. Over the years,we have seen and experienced personally the wonderful benefits of these high quality botanical products and are delighted to share them with others.


Arjuna Natural Extracts Ltd is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for over two decades. With customers in around 40 countries, the company has close to 50 patents to its credit of which majority are commercialized globally. The company has R&D tie ups with international universities from Australia, US and Japan. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.